William Blair Reaffirms Outperform Rating for LifeStance Health Group (NASDAQ:LFST)

LifeStance Health Group (NASDAQ:LFST)‘s stock had its “outperform” rating reiterated by equities research analysts at William Blair in a research note issued to investors on Friday,RTT News reports.

Several other equities analysts also recently issued reports on LFST. The Goldman Sachs Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a research report on Monday, December 16th. Barclays raised their price objective on LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th. One analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $8.70.

LifeStance Health Group Stock Performance

NASDAQ:LFST traded down $0.03 during trading hours on Friday, hitting $7.72. 871,111 shares of the company were exchanged, compared to its average volume of 1,182,347. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. LifeStance Health Group has a 52-week low of $4.64 and a 52-week high of $9.00. The stock has a market capitalization of $2.95 billion, a price-to-earnings ratio of -29.75 and a beta of 1.28. The company’s 50 day moving average price is $7.79 and its 200-day moving average price is $7.21.

Hedge Funds Weigh In On LifeStance Health Group

Several institutional investors and hedge funds have recently modified their holdings of the stock. Principal Financial Group Inc. boosted its position in LifeStance Health Group by 6.1% in the 3rd quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company’s stock worth $28,817,000 after purchasing an additional 235,316 shares in the last quarter. Jennison Associates LLC increased its holdings in LifeStance Health Group by 9.5% in the third quarter. Jennison Associates LLC now owns 2,136,942 shares of the company’s stock valued at $14,959,000 after buying an additional 184,896 shares in the last quarter. Intech Investment Management LLC purchased a new stake in shares of LifeStance Health Group during the 3rd quarter worth about $311,000. Landscape Capital Management L.L.C. increased its stake in shares of LifeStance Health Group by 43.7% in the 3rd quarter. Landscape Capital Management L.L.C. now owns 367,935 shares of the company’s stock valued at $2,576,000 after purchasing an additional 111,894 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in LifeStance Health Group by 36.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company’s stock worth $7,731,000 after purchasing an additional 297,723 shares during the period. Institutional investors and hedge funds own 85.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.